Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 18 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

7%

1 of 14 completed with results

Key Signals

1 with results100% success

Data Visualizations

Phase Distribution

14Total
Not Applicable (8)
Early P 1 (1)
P 1 (5)

Trial Status

Completed14
Unknown2
Suspended1
Recruiting1

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 14 completed trials

Clinical Trials (18)

Showing 18 of 18 trials
NCT07014735Not ApplicableRecruiting

Effect of Hyperglycaemia and Moxifloxacin on QTc Interval in T2DM

NCT05488470Completed

QT Changes as Detected From LINQ ECG During Antiarrhythmic Loading (LINQ QT)

NCT06822153Phase 1CompletedPrimary

Clinical Trial of the Effect of Methoxyethyl Etomidate Hydrochloride on the QT Interval of the Heart

NCT05757063Not ApplicableCompleted

Impact of Two Different Types of Sedation on ICEB

NCT04568395Not ApplicableCompleted

Acute Effects of TCIG vs ECIG in PLWH

NCT04005027Not ApplicableSuspendedPrimary

Exercise Induced QT Interval Changes in Response to Intermittent and Continuous Graded Exercise Tests

NCT04966325Early Phase 1Completed

Thorough QT (TQT) Study to Evaluate the Effect of LC350189 on Cardiac Repolarization in Healthy Male and Female Subjects

NCT04437901Unknown

COVIDAR - Arrhythmias in COVID-19

NCT04000542Not ApplicableCompleted

Pharmacist Use of ECG to Inform Drug Therapy Decisions for Patients Receiving QT Prolonging Medications

NCT02063620Not ApplicableCompletedPrimary

The Effect of Anesthetic Agents Management on ECG Changes of Patients Who Were Operated Under RIVA

NCT03822520Phase 1CompletedPrimary

Clinical Study to Evaluate Effect on QT/QTc Interval After Multiple Dose of Celecoxib

NCT03642405Unknown

Drug-induced Repolarization ECG Changes

NCT03475459Phase 1CompletedPrimary

Investigation of Arrhythmogenic Effect of NPC-15 (NPC-15-7)

NCT02492347Not ApplicableCompletedPrimary

Effect of Antenatal SSRI Exposure on the QT Interval of Neonates

NCT01365806Completed

Home Electrocardiogram (ECG) Monitoring After Heart Transplantation

NCT02924337Phase 1CompletedPrimary

Effect of Imeglimin on QT/QTc Intervals in Healthy Subjects

NCT02217930Phase 1CompletedPrimary

Study to Evaluate the Effect Of WCK 2349 on the QT/QTc Interval in Health Volunteers

NCT02241252Not ApplicableCompleted

Using an iPhone ECG to Monitor the QT Interval on Dofetilide and Sotalol Patients

Showing all 18 trials

Research Network

Activity Timeline